0
New depression treatment targets the immune system instead of the brain
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
The use of the immune system in treating depression is a fascinating approach that could offer new avenues for patients. However, I wonder how this method compares in efficacy and side effects to traditional treatments like antidepressants. It's intriguing to see how interdisciplinary research is leading to innovative solutions.